COMMUNIQUÉS West-GlobeNewswire

IO Biotech to Present at 44th Annual Cowen Health Care Conference
26/02/2024
NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating therapeutic cancer vaccines based on its T-win® platform, announced [...]
Lyell Immunopharma Announces Participation in March Investor Conferences
26/02/2024
SOUTH SAN FRANCISCO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with [...]
Clover Health to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
26/02/2024
FRANKLIN, Tenn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report fourth quarter and full year 2023 [...]
Revive Therapeutics Ltd. Announces Closing of the Second and Final Tranche of Its Private Placement for Gross Proceeds of $1,187,110
26/02/2024
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- REVIVE THERAPEUTICS [...]
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Korea
26/02/2024
The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place FibroGen to explore licensing opportunities for Roxadustat SAN FRANCISCO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) [...]
Xtant Medical to Present at the TD Cowen 44th Annual Healthcare Conference
26/02/2024
BELGRADE, Mont., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today [...]
Compass Pathways to participate in upcoming TD Cowen investor conference
26/02/2024
LONDON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that [...]
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
26/02/2024
–Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company’s current and future business operations– HORSHAM, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) -- STRATA [...]
Fate Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
26/02/2024
CIRM Grant Awarded to Support Phase 1 Autoimmunity Study of FT819 CD19-targeted CAR T-cell Program for Systemic Lupus Erythematosus; Study Start-up Ongoing at Multiple Clinical Sites First Patient Treated in Phase 1 [...]
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
26/02/2024
SAN FRANCISCO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief [...]
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31, 2023
26/02/2024
Topline data from vafidemstat's PORTICO Phase IIb trial in Borderline Personality Disorder (BPD) reported with promising results in secondary endpoints of overall severity and control of agitation/aggression Company [...]
Brain Canada launches Season 3 of Playing with Marbles podcast – inside youth mental health
26/02/2024
The Brain Canada – Vocal Fry production returns with Katie Jensen as host MONTREAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Playing with Marbles, Brain Canada’s English-language podcast on everything brain, is back. This [...]
La Fondation Brain Canada lance la saison 3 du balado Playing with Marbles - la santé mentale chez les jeunes
26/02/2024
La production de la Fondation Brain Canada et Vocal Fry, animée par Katie Jensen, est de retour MONTRÉAL, 26 févr. 2024 (GLOBE NEWSWIRE) -- Playing with Marbles, le balado anglais de la Fondation Brain Canada portant [...]
AB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALS
26/02/2024
PRESS RELEASE AB SCIENCE ANNOUNCES THAT HEALTH CANADA HAS ISSUED A NOTICE OF NON-COMPLIANCE-WITHDRAWAL (NON/w) FOR MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AB SCIENCE INTENDS TO SUBMIT A REQUEST FOR RECONSIDERATION [...]
AB Science annonce que Santé Canada a émis un Avis de Non-Conformité-Retrait (ANC-R) pour le masitinib dans la SLA
26/02/2024
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE QUE SANTÉ CANADA A ÉMIS UN AVIS DE NON-CONFORMITÉ-RETRAIT (ANC-R) POUR LE MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE AB SCIENCE A L'INTENTION DE DÉPOSER UNE DEMANDE DE [...]
Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report
26/02/2024
The 2023 global medtech outsourcing market grew more than 11% to $81.5B, demonstrating strong market resilience FRAMINGHAM, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Alira Health , a global life sciences advisory and [...]
BBS-Bioactive Bone Substitutes Plc: Financial Statements Bulletin 2023: Preparations for commercial phase initiated (unaudited)
26/02/2024
BBS-Bioactive Bone Substitutes Plc, Financial Statements Bulletin 2023, 26 February 2024 at 5.45 p.m. (EET) This is a summary of BBS-Bioactive Bone Substitutes Plc’s Financial Statements Bulletin for January–December [...]
Aclarion Announces Pricing of $3.0 Million Public Offering
26/02/2024
BROOMFIELD, CO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW) , a healthcare technology company that is leveraging biomarkers and proprietary [...]
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
26/02/2024
Telesis Bio announces Q4 and full-year 2023 select preliminary financial results, highlighting strong BioXp kit sales, expanding gross margin and reduced expense SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Telesis Bio [...]

Pages